Determination of imidocarb residues in bovine and ovine liver and milk by immunobiosensor

• Published in: Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment Vol. 30; no. 6; pp. 1108 - 1114
• Main Authors: Traynor, I.M, Thompson, C.S, Armstrong, L, Fodey, T, Danaher, M, Jordan, K, Kennedy, D.G, Crooks, S.R.H
• Format: Journal Article Conference Proceeding
• Language: English
• Published: Abingdon Taylor & Francis 01.06.2013
• Subjects: adverse effects; analytical methods; Animals; Antiprotozoal Agents - analysis; Biological and medical sciences; Biosensing Techniques; Biosensors; Biotechnology; Cattle; compliance; European Union; ewe milk; Food industries; Fundamental and applied biological sciences. Psychology; humans; imidocarb; Imidocarb - analysis; immunoassays; immunobiosensor; liver; Liver - chemistry; maximum residue limits; Methods. Procedures. Technologies; milk; Milk - chemistry; parasitoses; pharmacokinetics; Rabbits; residues; screening; Sheep; Various methods and equipments; veterinary drugs; Bovine; Liver; residues; Dairy product; Immunosensor; Antiprotozoal agent; Vertebrata; Mammalia; immunobiosensor; Residue; Biosensor; Parasiticide; Artiodactyla; Ungulata; Imidocarb; Milk
• ISSN: 1944-0057; 1944-0049; 1944-0057
• DOI: 10.1080/19440049.2013.779752

Imidocarb (IMD) is a veterinary drug that has been used for more than 30 years to treat and prevent parasitic diseases. Pharmacokinetic studies have shown that substantial levels of IMD residues are retained in the edible tissues and milk of cattle and sheep for up to 6 months after administration. This has led to concern regarding the potential adverse effects posed through human consumption of edible tissue or milk from treated animals if the recommended withdrawal periods for the drug are not properly implemented. While MRLs have been established by the European Union, it is important that analytical methods are available to monitor food samples for potentially violative levels of IMD residues. A qualitative biosensor-based immunoassay was developed to allow the detection of IMD at less than the European Union MRLs of 50 μg kg⁻¹ for milk and 2 mg kg⁻¹ for bovine and ovine liver. Validation of the developed methods provided a detection capability of <25 μg kg⁻¹ in milk and <0.75 mg kg⁻¹ in liver. A comparison study was undertaken, with IMD incurred milk and ovine liver samples analysed by the newly developed procedures and results compared with those obtained by LC-MS/MS. The newly developed screening method was applied to both incurred milk and liver samples. This faster, cheaper and reliable screening method has potential use in sample analysis to ensure compliance with legislative requirements.